跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG - HSA Drug Approval Details
Approvals
/
HSA
/
IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG
Approved
THERAPEUTIC
IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG
ACS DOBFAR S.P.A (PRIMARY AND SECONDARY PACKAGER) - ITALYACS DOBFAR SPA (STERILE BULK BLEND) (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
Mar 26, 2015
Approval ID
df25cfdb0604a62e
Company
ACS DOBFAR S.P.A (PRIMARY AND SECONDARY PACKAGER) - ITALYACS DOBFAR SPA (STERILE BULK BLEND) (ITALY)
Type
Therapeutic
Approval Details
Approval Id
df25cfdb0604a62e
Drug Name
IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG
Product Name
IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG
Approval Number
SIN14765P
Approval Date
2015-03-26
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DH51
Atc Item Name
imipenem and cilastatin
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Imipenem Monohydrate 530mg/vial eqv Imipenem
500mg/ vial
Sodium Cilastatin 530mg/vial eqv Cilastatin
500mg/ vial
IMIPENEM MONOHYDRATE 530 MG/VIAL EQV IMIPENEM
500 MG/VIAL
SODIUM CILASTATIN 530 MG/VIAL EQV CILASTATIN
500 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 26, 2015
Approval ID
df25cfdb0604a62e
Type
Therapeutic
Back to HSA Approvals